PERNOD RICARD financials
PERNOD RICARD
52990097YFPX9J0H5D87 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Cost of sales | €4.44B | €4.62B |
| Gross profit | €6.52B | €6.97B |
| Operating profit (EBIT) | €2.74B | €2.72B |
| Net finance income / (cost) | -€492.0M | -€437.0M |
| Finance costs | €584.0M | €505.0M |
| Income tax expense | €574.0M | €766.0M |
| Profit for the year | €1.67B | €1.51B |
| — attributable to owners | €1.63B | €1.48B |
| — attributable to NCI | €48.0M | €38.0M |
| Total comprehensive income | €612.0M | €1.64B |
| Per share | ||
| Basic EPS | €6.47 | €5.84 |
| Diluted EPS | €6.45 | €5.83 |
| Cash flow statement | ||
| Net cash from operating activities | €1.79B | €1.73B |
| Net cash from investing activities | -€521.0M | -€676.0M |
| Net cash from financing activities | -€2.40B | -€209.0M |
| Dividends paid | €1.20B | €1.21B |
| Proceeds from borrowings | €978.0M | €2.81B |
| Repayments of borrowings | €2.05B | €1.36B |
| Lease liability payments | €113.0M | €125.0M |
| Net change in cash | -€1.13B | €842.0M |
| Balance sheet | ||
| Total assets | €37.08B | €39.19B |
| Non-current assets | €24.72B | €25.73B |
| Intangible assets & goodwill | €6.41B | €6.81B |
| Inventories | €8.42B | €8.26B |
| Trade & other receivables | €1.48B | €1.58B |
| Cash & equivalents | €1.83B | €2.68B |
| Total equity | €16.23B | €16.80B |
| — attributable to owners | €15.21B | €15.75B |
| Non-controlling interests | €1.01B | €1.05B |
| Non-current liabilities | €14.40B | €15.15B |
| Lease liabilities (non-current) | €344.0M | €352.0M |
| Lease liabilities (current) | €91.0M | €96.0M |
| Deferred tax liabilities | €3.06B | €3.15B |
| Derived metrics | ||
| Operating margin | 25.0% | 23.5% |
| Net margin | 15.3% | 13.1% |
| Return on equity | 10.3% | 9.0% |
| Cash conversion ratio | 1.07× | 1.14× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense | €422.0M | €441.0M |
| Adjustments For Finance Income Cost | -€492.0M | -€437.0M |
| Adjustments For Gains Losses On Change In Fair Value Less Costs To Sell Biological Assets | €4.0M | €5.0M |
| Adjustments For Gains Losses On Change In Fair Value of Derivatives | €3.0M | -€5.0M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €52.0M | €495.0M |
| Adjustments For Income Tax Expense | €574.0M | €766.0M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€93.0M | -€292.0M |
| Adjustments For Provisions | -€42.0M | -€37.0M |
| Adjustments For Sharebased Payments | €25.0M | €45.0M |
| Advertising Expense | €1.68B | €1.87B |
| Cash Flows From Used In Operations Before Changes In Working Capital | €3.10B | €3.38B |
| Comprehensive Income Attributable To Noncontrolling Interests | -€42.0M | €51.0M |
| Comprehensive Income Attributable To Owners of Parent | €653.0M | €1.59B |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €12.29B | €13.06B |
| Current Bonds Issued and Current Portion of Noncurrent Bonds Issued | €1.24B | €1.78B |
| Current Derivative Financial Assets | €18.0M | €8.0M |
| Current Derivative Financial Liabilities | €17.0M | €21.0M |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | €6.44B | €7.09B |
| Current Provisions | €147.0M | €158.0M |
| Current Tax Assets Current | €99.0M | €122.0M |
| Current Tax Liabilities Current | €203.0M | €149.0M |
| Deferred Tax Assets | €1.52B | €1.71B |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | €1.19B | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €4.70 | — |
| Dividends Recognised As Distributions To Owners Per Share | €4.70 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €275.0M | €232.0M |
| Equity and Liabilities | €37.08B | €39.19B |
| Finance Income | €92.0M | €68.0M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | €0 | €0 |
| Income Tax Relating To Hedges of Net Investments In Foreign Operations of Other Comprehensive Income | €10.0M | -€4.0M |
| Income Tax Relating To Investments In Equity Instruments of Other Comprehensive Income | €35.0M | -€6.0M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | -€8.0M | €5.0M |
| Income Taxes Paid Refund Classified As Operating Activities | €417.0M | €547.0M |
| Increase Decrease In Cash and Cash Equivalents | -€854.0M | €1.07B |
| Increase Decrease In Cash and Cash Equivalents Discontinued Operations | €0 | €0 |
| Increase Decrease In Working Capital | €470.0M | €768.0M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | -€6.0M | €5.0M |
| Increase Decrease Through Sharebased Payment Transactions | €26.0M | €45.0M |
| Increase Decrease Through Transfers and Other Changes Equity | -€1.0M | -€6.0M |
| Increase Decrease Through Treasury Share Transactions | -€9.0M | -€333.0M |
| Intangible Assets Other Than Goodwill | €11.52B | €12.23B |
| Interest Paid Classified As Operating Activities | €443.0M | €355.0M |
| Interest Received Classified As Operating Activities | €17.0M | €19.0M |
| Investment Accounted For Using Equity Method | €68.0M | €58.0M |
| Issued Capital | €391.0M | €393.0M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €7.0M | €151.0M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €65.0M | €395.0M |
| Noncurrent Derivative Financial Assets | €36.0M | €0 |
| Noncurrent Derivative Financial Liabilities | €1.0M | €11.0M |
| Noncurrent Portion of Noncurrent Bonds Issued | €10.34B | €10.91B |
| Noncurrent Portion of Other Noncurrent Borrowings | €96.0M | €133.0M |
| Noncurrent Provisions For Employee Benefits | €265.0M | €277.0M |
| Other Adjustments To Reconcile Profit Loss | €0 | €0 |
| Other Comprehensive Income | -€1.06B | €127.0M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | -€1.0M | -€1.0M |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | €58.0M | €3.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€23.0M | €32.0M |
| Other Comprehensive Income Before Tax Hedges of Net Investments In Foreign Operations | €37.0M | -€15.0M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | -€1.0M | -€1.0M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€1.10B | €103.0M |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | €23.0M | €9.0M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€15.0M | €27.0M |
| Other Comprehensive Income Net of Tax Hedges of Net Investments In Foreign Operations | €28.0M | -€11.0M |
| Other Current Assets | €445.0M | €416.0M |
| Other Current Borrowings and Current Portion of Other Noncurrent Borrowings | €478.0M | €352.0M |
| Other Current Liabilities | €1.55B | €1.61B |
| Other Inflows Outflows of Cash Classified As Financing Activities | €4.0M | €0 |
| Other Longterm Provisions | €298.0M | €313.0M |
| Other Operating Income Expense | -€208.0M | -€392.0M |
| Profit Loss From Discontinued Operations | €0 | €0 |
| Property Plant and Equipment Including Rightofuse Assets | €4.21B | €3.98B |
| Retained Earnings Profit Loss For Reporting Period | €1.63B | €1.48B |
| Revenue From Contracts With Customers | €10.96B | €11.60B |
| Selling General and Administrative Expense | €1.89B | €1.99B |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | -€3.0M | -€7.0M |
| Share Premium | €3.05B | €3.05B |
| Trade and Other Current Payables To Trade Suppliers | €2.71B | €2.93B |
Every line item above is a fact tagged in PERNOD RICARD's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.